Vav3 Enhances Androgen Receptor Splice Variant Activity and Is Critical for Castration-Resistant Prostate Cancer Growth and Survival

Overview of attention for article published in Endocrinology, September 2012

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

patent: 3 patents

Readers on

mendeley: 34 Mendeley

So far, Altmetric has seen 3 patents that reference this research output.

Fluorogenic probes and their use in quantitative detection of target RNA sequences

Grant US-10400274-B2

United States of America

Use of arginine vasopressin receptor antagonists for the treatment of prostate cancer

Grant US-10231952-B2

United States of America

METHODS FOR IDENTIFYING ANDROGEN RECEPTOR SPLICE VARIANTS IN SUBJECTS HAVING CASTRATION…

Application EP-3146081-A4

European Patent Office

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity.